340B Drug Pricing Program
It’s in everyone’s best interest to keep the 340B program strong, wrote AHA President and CEO Rick Pollack in the Congress Blog at The Hill, published Oct. 10.
“For three decades, the 340B drug pricing program has helped hospitals that serve high numbers of low-income patients offer and expand a range of important programs and services that advance health within their communities,” writes AHA President and CEO Rick Pollack in the Congress Blog at The Hill…
After court ruling for AHA in 340B case, HHS says it will start adjusting payment rates for certain 340B hospitals within approximately two weeks
The Department of Health and Human Services will begin restoring a payment rate of average sales price plus 6% for 340B drug claims in about two weeks, the department told a United States District Court for the District of Columbia.
The United States District Court for the District of Columbia Sept 28 ruled in favor of the AHA, holding that the Department of Health and Human Services must immediately halt the departments’ unlawful cuts to outpatient reimbursement rates for the remainder of 2022 for certain hospitals that…
The AHA appreciates Judge Contreras’ ruling that the Department of Health and Human Services must immediately stop unlawful reimbursement cuts for 2022 for hospitals participating in the 340B drug pricing program. Halting these cuts will help 340B hospitals provide comprehensive health services to…
The United States District Court for the District of Columbia today ruled in favor of the AHA, holding that the Department of Health and Human Services must immediately halt the departments’ unlawful cuts to outpatient reimbursement rates for the remainder of 2022 for certain hospitals that…
The United States District Court for the District of Columbia ruled in favor of the AHA, holding that HHS must immediately halt the departments’ unlawful cuts to outpatient reimbursement rates for the remainder of 2022 for certain hospitals that participate in the 340B Drug Pricing Program.
This page contains materials related to AHA’s current and active policy-related litigation.
Judge orders HHS to immediately halt unlawful reimbursement cuts for remainder of 2022 re: 340B.